P

Inventor

WEBER ECKARD

US73 patents
⚠️ This page may combine multiple inventors who share the name “WEBER ECKARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

OREGON STATE

24 patents
US5514680AMay 7, 1996

Glycine receptor antagonists and the use thereof

OREGON STATE206 citations99
US5093525AMar 3, 1992

N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists

OREGON STATE124 citations98
US5262568ANov 16, 1993

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

OREGON STATE91 citations97
US5336689AAug 9, 1994

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

OREGON STATE90 citations96
US5312840AMay 17, 1994

Substituted guanidines having high binding to the sigma receptor and the use thereof

OREGON STATE51 citations96
US5308869AMay 3, 1994

Substituted amidines having high binding to the sigma receptor and the use thereof

OREGON STATE49 citations96
US5190976AMar 2, 1993

N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists

OREGON STATE107 citations96
US5798390AAug 25, 1998

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

OREGON STATE26 citations93
US5559154ASep 24, 1996

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

OREGON STATE20 citations93
US5385946AJan 31, 1995

Method for treating hypertension with disubstituted granidine compounds

OREGON STATE66 citations93
US4906779AMar 6, 1990

N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists

OREGON STATE115 citations93
US5620978AApr 15, 1997

8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor

OREGON STATE34 citations92
US5597922AJan 28, 1997

Glycine receptor antagonist pharmacophore

OREGON STATE22 citations92
US5011834AApr 30, 1991

PCP receptor ligands and the use thereof

OREGON STATE40 citations92
US4709094ANov 24, 1987

Sigma brain receptor ligands and their use

OREGON STATE82 citations91
US5502255AMar 26, 1996

Substituted guanidines having high binding to the sigma receptor and the use thereof

OREGON STATE21 citations89
US6251948B1Jun 26, 2001

Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists

OREGON STATE17 citations84
US4975430ADec 4, 1990

CNQX and its analogs as therapeutics for degenerative neural diseases

OREGON STATE28 citations84
US5637622AJun 10, 1997

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

OREGON STATE13 citations82
US5622952AApr 22, 1997

Glycine receptor antagonists and the use thereof

OREGON STATE14 citations82
US5478863ADec 26, 1995

Substituted guanidines having high binding to the sigma receptor and the use thereof

OREGON STATE16 citations82
US5631373AMay 20, 1997

Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones

OREGON STATE14 citations81
US5767162AJun 16, 1998

Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists

OREGON STATE11 citations74
US5620979AApr 15, 1997

Glycine receptor antagonists and the use thereof

OREGON STATE7 citations74

CYTOVIA INC

7 patents

NOVALAR PHARMACEUTICALS INC

7 patents

OREXIGEN THERAPEUTICS INC

3 patents

WARNER LAMBERT CO

3 patents

MCKINNEY ANTHONY

3 patents

EURO CELTIQUE SA

1 patent

NALPROPION PHARMACEUTICALS LLC

1 patent

NALPROPION PHARMACEUTICALS INC

1 patent

Showing the top 50 of 73 patents by PatentIndex Score.